2/25/11 Contest Update
The Bulls got tripped up by the tumult in Tripoli, but Friday’s rally substantially trimmed the week’s losses.
At Friday’s close, the Nasdaq Biotech Index was up 1.27% YTD (vs. up 2.21% YTD a week ago) and the Contest median was up .73% YTD (vs. up .03% YTD a week ago). The Nasdaq Composite Index was up 4.83% YTD (vs. up 6.83% YTD a week ago).
Nice moves by ACHN and TSRX helped boost MCBIO’s portfolio (up 18.79% YTD) into first place. GENE’s portfolio (up 16.99% YTD) fell back to second place, with RKRW’s portfolio (up 15.81% YTD) in the No. 3 slot.
At Friday's close, 20 of the 38 Contest portfolios were in the black with 18 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None.
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
2/25/11
Rank Name Profit/Loss
1 MCBIO 18,786
2 GENE 16,987
3 RKRW 15,807
4 RRGE 15,272
5 JIBAC 7,345
6 ROCKY 6,890
7 IJF 5,863
8 GEORGIA 5,617
9 IMAN 5,515
10 CRAZYP 4,094
Week's Top 5 Gainers
Symbol 2/18 2/25 % change
ACHN 4.98 5.85 17.47%
NEOP 3.68 4.29 16.58%
VRTX 39.16 44.84 14.50%
TSRX 5.57 6.24 12.03%
EXEL 10.76 11.82 9.85%
Week's Top 5 Losers
Symbol 2/18 2/25 % change
DCTH 11.30 6.29 -44.34%
VSCP 2.65 2.10 -20.94%
PLX 9.62 7.63 -20.69%
QCOR 14.23 12.61 -11.38%
DYAX 1.94 1.72 -11.34% |
